MicroPort Orthopedics Receives Long-Term ODEP Rating for its Advance® Medial-Pivot Knee System

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, has received a “15A” rating for its Advance® Medial-Pivot knee system from the Orthopaedic Data Evaluation Panel (ODEP).

Fifteen (15) years is the longest benchmark that ODEP assigns ratings for knee implants, providing further evidence of the long clinical heritage of the Advance® Medial-Pivot knee system. ODEP was established in 2002, and provides an independent review of clinical data to assign ratings and share information about the success of arthroplasty implants.

MicroPort Orthopedics’ medial-pivot knee systems stand on more than 20 years of clinically demonstrated history with a complete portfolio of medial-pivot design knees. The Advance® Medial-Pivot knee system was built on the latest kinematic evidence of the natural stability and motion of the knee.1 Its innovative design is carried on by MicroPort’s latest medial-pivot knee, the Evolution® Medial-Pivot knee system, which also aims to restore function by replicating natural motion and stability, and to address some of the common problems seen with traditional designs, such as anterior knee pain and quadriceps avoidance.

The design and successful clinical heritage of MicroPort Orthopedics’ medial-pivot knee systems sets them apart from the competition. A legacy of 98.8 percent survivorship over 17 years and 95 percent patient satisfaction supports its ability to restore stability and normal kinematics. This helps surgeons achieve favorable, reproducible, and long-lasting outcomes for their patients. 2-5
 
“It’s our goal at MicroPort to develop innovative products and procedures that help providers improve patient outcomes, facilitate fast recovery and a return to normal life activities,” says Irina Timmerman, the Vice President of Regulatory and Clinical Affairs at MicroPort Orthopedics. “This rating from ODEP further validates MicroPort’s medial-pivot knee systems’ ability to produce consistent and long-lasting results.”

REFERENCES

1. George A. Macheras et al. “A long term clinical outcome of the Medial Pivot Knee Arthroplasty System.” The Knee Journal, January 29, 2017.

2. Patient satisfaction at 2 months following total knee replacement using a second generation medial-pivot system: follow-up of 250 consecutive cases. Van Overschelde P et al. Ann Transl Med 2016

3. Pritchett JW. Patients prefer a bicruciate-retaining or the medial pivot total knee prosthesis. J Arthroplasty. 2011;26:224–228.

4. Miyazaki Y et al. Analysis of the Kinematics of Total Knee Prostheses With a Medial Pivot Design. J Arthroplasty. 2011; 26(7):1038-1044.

5. Lamontagne M et al.. Muscle Activity in Total Knee Arthroplasty Patients While Ascending and Descending a Ramp. Orthopaedic Proceedings, 2019. 101-B(SUPP_5): p. 59-59.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version